Ovarian Carcinoma
📧 Sign up to get email alerts when something new happens for Ovarian Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer [Phase 2]
A Phase 2 trial sponsored by Mayo Clinic compares at-home cancer-directed therapy to in-clinic treatment for patients with various advanced …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Prophylactic Salpingectomy With Delayed Oophorectomy [NA]
This entry updates a clinical trial evaluating prophylactic salpingectomy with delayed oophorectomy for ovarian carcinoma, currently listed …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating genetically modified T cells in combination with decitabine for recurrent or refractory ovarian,…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of cabozantinib (XL184) and nivolumab in patients with various advanced cancers …
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. [Phase 1]
Phase 1 study of PF-07826390 in cancer patients, including non-small cell lung cancer, was terminated; the trial evaluated different doses o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy [NA]
An ongoing clinical trial is evaluating whether dietary magnesium can prevent hypomagnesemia in patients with ovarian carcinoma receiving ca…
-
CLINICAL_TRIALS other · 2026-01-14Clinical Trial Update: Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) [NA]
The HOPE trial for recurrent ovarian carcinoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Prediction of Ovarian Cancer Histotypes and Surgical Outcome
This update describes a clinical trial investigating histotype prediction in ovarian cancer and the associated surgical outcomes. The study …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a neoantigen-based dendritic cell vaccine (NEOadjuvant) for ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update of sapanisertib with ziv-aflibercept in patients with recurrent, metastatic, or unresectable solid tumors, including fi…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS other · 2025-05-15Clinical Trial Update: NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma [Phase 4]
Clinical trial status update for a Phase 4 study evaluating an NGS-based germline and somatic genetic test in ovarian carcinoma and related …
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) [Phase 2]
Phase 2 trial MK-4830-002 evaluating pembrolizumab with chemotherapy and MK-4830 in ovarian cancer has completed enrollment with results pos…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
The NCT01445275 trial on the cost of cancer risk management in women at elevated genetic risk for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results
This clinical trial proposes a fast diffusion-weighted MRI protocol to surveil patients at high risk of ovarian cancer recurrence who are on…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of PF-07209960 in advanced or metastatic solid tumors was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis
This ClinicalTrials.gov entry notes an international registration to investigate the risk of serous peritoneal carcinomatosis associated wit…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating dalpiciclib in combination with letrozole for recurrent ovarian carcinoma in HR+/HER2-negative gynecolog…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]
Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression [Phase 2]
A phase 2 trial comparing regorafenib to tamoxifen in platinum-sensitive ovarian carcinoma with isolated biological progression has complete…